Sign inJoin waitlistJoin the waitlist

AG

Ayca Gucalp

Assistant Attending Physician · New York Presbyterian Hospital

Credentials: · · ·

History

New York Presbyterian Hospital
Present

Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
2008–2011
Memorial Sloan Kettering Cancer Center
2005–2008
Albert Einstein College of Medicine
2001–2005

Research

Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation
Review · Journal of Clinical Oncology · 2016 · 826 citations
Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer
Clinical Cancer Research · 2013 · First of 23 authors · 565 citations
American Society of Clinical Oncology position statement on obesity and cancer
Journal of Clinical Oncology · 2014 · 411 citations

TT
Tiffany Traina
19 papers
CH
Clifford Hudis
14 papers
Neil Iyengar
11 papers · 8 as a fellow
AD
Andrew Dannenberg
9 papers
DG
Dilip Giri
7 papers
MM
Monica Morrow
5 papers
PM
Patrick Morris
5 papers
Mario Lacouture
4 papers · 1 as a fellow
CD
Chau Dang
3 papers
DY
Denise Yardley
3 papers
DL
Diana Lake
3 papers
JB
Jacqueline Bromberg
3 papers

Clinical trials

A Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2022–2027
Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)
Principal investigator · Active not recruiting · Phase 1, Phase 2
Memorial Sloan Kettering Cancer Center
2015–2026
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
2013–2020